J. Wan, Z. Zhao, F. Wang, X. Ma
FULL PAPER
3
6.96–6.97 (m, 2 H), 5.77 (s, 1 H), 4.56 (d, J = 7.2 Hz, 2 H), 3.68–
3.73 (m, 1 H), 2.57–2.64 (m, 2 H), 2.33 (s, 3 H), 2.26–2.29 (m, 2
H), 2.14–2.24 (m, 2 H), 1.88–1.93 (m, 2 H) ppm. 13C NMR
(150.9 MHz, CDCl3): δ = 199.1, 161.1, 138.9, 137.9, 129.0, 128.9,
128.3, 128.0, 124.3, 80.1, 42.1, 41.5, 37.1, 29.5, 22.5, 21.4 ppm. MS:
m/z = 274.2 [M + H]+. C16H19NO3 (273.33): calcd. C 70.31, H 7.01,
N 5.12; found C 70.24, H 7.02, N 5.10.
5.4 Hz, 1 H), 3.85–3.90 (m, 2 H), 3.33 (cis, dd, J = 16.2, 10.2 Hz,
0.5 H), 3.26 (dd, J = 16.2, 8.4 Hz, 1 H), 3.08 (cis, dd, J = 15.6,
6.0 Hz, 0.56 H), 3.01 (trans, dd, J = 16.2, 5.4 Hz, 1.13 H), 2.75–
2.91 (m, cis, 1 H, trans, 2 H) ppm. 13C NMR (150.9 MHz, CDCl3):
δ = (trans) 206.6, 141.3, 136.5, 135.2, 130.6, 129.0, 128.5, 128.4,
127.6, 127.2, 125.4, 91.0, 43.6, 42.6, 42.0, 41.9; (cis) 206.9, 139.2,
138.9, 134.9, 130.2, 129.4, 128.6, 128.2, 127.8, 127.5, 125.6, 91.3,
42.9, 42.5, 41.3, 41.2 ppm. MS: m/z = 330.1 [M + H]+ .
C18H16ClNO3 (329.78): calcd. C 65.56, H 4.89, N 4.25; found C
65.49, H 4.91, N 4.21.
(R)-3-[2-(2-Methoxyphenyl)-3-nitropropyl]cyclohex-2-enone:
1
52.0 mg, 90%, 99% ee, [α]D = –10.6 (c = 1.00, CHCl3). H NMR
3
3
(600.1 MHz, CDCl3): δ = 7.24 (d, J = 7.2 Hz, 1 H), 7.06 (d, J =
7.8 Hz, 1 H), 6.87–6.91 (m, 2 H), 5.74 (s, 1 H), 4.71 (dd, J = 12.6, (3S,4R,5S)-4-Nitro-3-phenyl-5-(o-tolyl)cyclohexanone: 47.0 mg,
6.6 Hz, 1 H), 4.63 (dd, J = 12.6, 7.8 Hz, 1 H), 4.01–4.06 (m, 1 H), 76%, dr (trans/cis) = 14.3:1, 90% ee (trans), [α]D = –71.7 (c = 1.35,
3.86 (s, 3 H), 2.75 (dd, J = 13.8, 9.6 Hz, 1 H), 2.63 (dd, J = 13.8,
CHCl3). 1H NMR (600.1 MHz, CDCl3): δ = 7.31–7.34 (m, 3 H),
6.0 Hz, 1 H), 2.17–2.30 (m, 4 H), 1.81–1.92 (m, 2 H) ppm. 13C 7.19–7.23 (m, 4 H), 7.07 (d, 3J = 6.0 Hz, 2 H), 5.25 (dd, J = 6.6,
NMR (150.9 MHz, CDCl3): δ = 199.2, 162.0, 157.2, 129.3, 128.9, 4.8 Hz, 1 H), 4.17 (trans, q, 3J = 7.2 Hz, 1 H), 4.09 (cis, q, 3J =
128.0, 125.8, 121.0, 111.3, 78.7, 55.4, 39.9, 38.1, 37.2, 29.5,
5.4 Hz, 0.07 H), 3.83–3.86 (m, 1 H), 3.33 (dd, J = 15.6, 9.0 Hz, 1
22.6 ppm. MS: m/z = 290.1 [M + H]+. C16H19NO4 (289.33): calcd. H), 3.03 (dd, J = 16.2, 6.0 Hz, 1 H), 2.88 (dd, J = 16.2, 6.0 Hz, 1
C 66.42, H 6.62, N 4.84; found C 66.37, H 6.70, N 4.75.
H), 2.73 (dd, J = 16.2, 7.8 Hz, 1 H), 2.33 (trans, s, 3 H), 1.90 (cis,
s, 0.20 H) ppm. 13C NMR (150.9 MHz, CDCl3): δ = 207.7, 137.9,
137.0, 136.0, 131.4, 129.0, 128.3, 127.8, 127.5, 127.0, 125.5, 90.2,
43.4, 42.3, 41.9, 38.3, 19.2 ppm. MS: m/z = 310.2 [M + H]+.
(R)-3-[2-(3-Methoxyphenyl)-3-nitropropyl]cyclohex-2-enone:
53.7 mg, 93%, 97% ee, [α]D = –8.7 (c = 1.10, CHCl3). 1H NMR
3
3
(600.1 MHz, CDCl3): δ = 7.25 (t, J = 7.8 Hz, 1 H), 7.06 (d, J =
C
19H19NO3 (309.36): calcd. C 73.77, H 6.19, N 4.53; found C
3
7.8 Hz, 1 H), 6.81 (dd, J = 8.4, 2.4 Hz, 1 H), 6.76 (d, J = 7.2 Hz,
73.70, H 6.14, N 4.46.
3
1 H), 6.70 (s, 1 H), 5.78 (s, 1 H), 4.57 (d, J = 7.2 Hz, 2 H), 3.79
(s, 3 H), 2.57–2.64 (m, 2 H), 2.26–2.30 (m, 2 H), 2.15–2.25 (m, 2 (3S,4R,5S)-4-Nitro-3-phenyl-5-(m-tolyl)cyclohexanone: 49.5 mg,
H), 1.89–1.94 (m, 2 H) ppm. 13C NMR (150.9 MHz, CDCl3): δ = 80%, dr (trans/cis) = 4.2:1, 93% ee (trans), [α]D = –95.7 (c = 1.18,
198.9, 160.8, 160.2, 139.6, 130.3, 128.4, 119.5, 113.8, 113.1, 80.1,
CHCl3). 1H NMR (600.1 MHz, CDCl3): δ = 7.30–7.34 (m, 3 H),
7.24–7.27 (m, 1 H), 7.11 (d, J = 7.2 Hz, 1 H), 7.04–7.08 (m, 4 H),
3
55.3, 42.2, 41.5, 37.2, 29.6, 22.6 ppm. MS: m/z = 290.1 [M + H]+.
C
16H19NO4 (289.33): calcd. C 66.42, H 6.62, N 4.84; found C
5.29 (dd, J = 7.2, 4.8 Hz, 1 H), 3.95 (cis, dd, J = 13.8, 6.6 Hz, 0.24
H), 3.90 (trans, dd, J = 13.8, 6.6 Hz, 1 H), 3.78–3.81 (m, 1 H), 3.32
(dd, J = 15.6, 9.0 Hz, 1 H), 3.35 (dd, J = 16.2, 6.0 Hz, 1 H), 2.81–
2.86 (m, 2 H), 2.35 (trans, s, 3 H), 2.31 (cis, s, 0.71 H) ppm. 13C
NMR (150.9 MHz, CDCl3): δ = 207.5, 139.4, 139.1, 136.9, 129.2,
128.9, 128.8, 128.3, 128.0, 127.5, 124.1, 91.6, 43.2, 42.5, 42.1, 41.7,
21.4 ppm. MS: m/z = 310.2 [M + H]+. C19H19NO3 (309.36): calcd.
C 73.77, H 6.19, N 4.53; found C 73.67, H 6.21, N 4.49.
66.40, H 6.69, N 4.78.
General Procedure for Cyclic Double-Michael Organocascade Reac-
tion: To toluene (1 mL) solution of H-CDNH2 (11.8 mg,
4ϫ10–2 mmol), o-fluorobenzoic acid (8.4 mg, 6ϫ10–2 mmol) was
added at room temperature whilst stirring. After 10 min, (E)-4-
phenylbut-3-en-2-one (58.4 mg, 0.4 mmol) was added, immediately
followed by β-nitrostyrene (29.8 mg, 0.2 mmol). The reaction mix-
ture was stirred at 40 °C for 48 h. To the organic phase was added
toluene (4 mL), and the mixture was extracted with hydrochloric
(3S,4R,5S)-4-Nitro-3-phenyl-5-(p-tolyl)cyclohexanone: 50.1 mg,
81%, dr (trans/cis) = 7.7:1, 89% ee (trans), [α]D = –108.6 (c = 1.27,
acid solution (pH = 0, 5 mLϫ3), dried with anhydrous Na2SO4, CHCl3). 1H NMR (600.1 MHz, CDCl3): δ = 7.30–7.36 (m, 3 H),
evaporated under reduced pressure and purified by flash column
chromatography using petroleum ether/ethyl acetate (v/v = 8:1) as 4.8 Hz, 1 H), 3.91 (dd, J = 13.8, 7.2 Hz, 1 H), 3.75–3.79 (m, 1 H),
7.12–7.18 (m, 4 H), 7.06 (d, 3J = 6.6 Hz, 2 H), 5.26 (dd, J = 6.6,
eluent to afford the pure adduct. The pH of the combined aqueous
phases was adjusted by aqueous ammonia to pH = 9–10, extracted
with toluene (5 mLϫ3) and concentrated under reduced pressure
to one-fifth of its original volume. The recovered H-CDNH2 was
used directly for following Michael/Michael cascade reactions. The
data of the new products are shown as follows.
3.33 (dd, J = 15.6, 9.0 Hz, 1 H), 3.13 (cis, dd, J = 6.6, 4.8 Hz, 1
H), 3.05 (trans, dd, J = 16.2, 6.0 Hz, 1 H), 2.80–2.85 (m, 2 H), 2.34
(trans, s, 2.6 H), 2.32 (cis, s, 0.35 H) ppm. 13C NMR (150.9 MHz,
CDCl3): δ = 207.6, 137.8, 136.9, 136.4, 129.9, 129.6, 129.3, 128.9,
128.3, 127.5, 127.1, 91.7, 43.1, 42.3, 41.9, 41.7, 21.0 ppm. MS: m/z
= 310.2 [M + H]+. C19H19NO3 (309.36): calcd. C 73.77, H 6.19, N
4.53; found C 73.69, H 6.22, N 4.51.
(3S,4R,5S)-3-(2-Chlorophenyl)-4-nitro-5-phenylcyclohexanone:
50.0 mg, 76%, dr (trans/cis) = 8.9:1, 90% ee (trans), [α]D = –80.3 (c
(3S,4R,5S)-3-(2-Methoxyphenyl)-4-nitro-5-phenylcyclohexanone:
53.3 mg, 82%, dr (trans/cis) = 24.5:1, 93%ee (trans), [α]D = –105.2
1
= 0.96, CHCl3). H NMR (600.1 MHz, CDCl3): δ = 7.44 (dd, J =
7.8, 1.8 Hz, 1 H), 7.27–7.35 (m, 6 H), 7.06 (d, 3J = 6.0 Hz, 2 H),
(c = 1.36, CHCl3). H NMR (600.1 MHz, CDCl3): δ = 7.27–7.32
1
3
5.36 (t, J = 4.8 Hz,1 H), 4.42 (dd, J = 12.6, 6.6 Hz, 1 H), 3.71–
(m, 4 H), 7.14 (d, 3J = 7.2 Hz, 1 H), 7.07 (d, J = 7.2 Hz, 2 H),
3
3.74 (m, 1 H), 3.38 (dd, J = 16.2, 10.8 Hz, 1 H), 3.19 (dd, J = 16.2,
6.93–6.96 (m, 2 H), 5.39 (t, J = 4.8 Hz, 1 H), 4.17 (t, J = 6.6 Hz,
6.6 Hz, 1 H), 2.83 (trans, dd, J = 16.2, 6.0 Hz, 2 H), 2.78 (cis, dd, 1 H), 3.88 (s, 3 H), 3.72–3.75 (m, 1 H), 3.35 (dd, J = 16.2, 11.4 Hz,
J = 17.4, 3.0 Hz, 0.22 H) ppm. 13C NMR (150.9 MHz, CDCl3): δ
= 207.6, 139.2, 134.2, 133.7, 129.9, 129.4, 129.3, 128.2, 128.1, 127.5,
127.5, 89.5, 43.7, 41.2, 39.9, 36.9 ppm. MS: m/z = 330.1 [M +
H]+. C18H16ClNO3 (329.78): calcd. C 65.56, H 4.89, N 4.25; found
C 65.51, H 4.93, N 4.18.
1 H), 3.07 (dd, J = 16.2, 6.6 Hz, 1 H), 2.97 (dd, J = 16.8, 7.2 Hz,
1 H), 2.77 (trans, dd, J = 16.2, 4.8 Hz, 1 H), 2.66 (cis, dd, J = 16.8,
3.6 Hz, 0.04 H) ppm. 13C NMR (150.9 MHz, CDCl3): δ = 208.5,
156.7, 137.2, 129.3, 128.9, 128.8, 128.1, 127.6, 127.4, 121.2, 111.2,
89.6, 55.4, 41.9, 41.4, 41.0, 39.1 ppm. MS: m/z = 326.1 [M + H]+.
C19H19NO4 (325.36): calcd. C 70.14, H 5.89, N 4.31; found C
70.08, H 5.92, N 4.29.
(3S,4R,5S)-3-(3-Chlorophenyl)-4-nitro-5-phenylcyclohexanone:
53.3 mg, 81%, dr (trans/cis) = 2.0:1, 94% ee trans, [α]D = –98.6 (c
1
= 1.19, CHCl3). H NMR (600.1 MHz, CDCl3): δ = 7.31–7.33 (m, (3S,4R,5S)-3-(3-Methoxyphenyl)-4-nitro-5-phenylcyclohexanone:
3 H), 7.27–7.29 (m, 4 H), 7.05–7.07 (m, 2 H), 5.30 (dd, J = 7.8, 52.0 mg, 80%, dr (trans/cis) = 9.4:1, 93% ee (trans), [α]D = –118.9
5762
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 5755–5763